Fondation Fournier-Majoie
Overview
Fondation Fournier-Majoie is a Belgian non-profit foundation that identifies, finances, and provides entrepreneurial support to researchers and startups to develop innovations in the oncology sector.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ATB Therapeutics | Dec 2019 | Seed | Lead |
| Precirix | Oct 2014 | Seed | Co-investor |
| HEPHAISTOS-Pharma | May 2024 | Seed | Co-investor |
| Apmonia Therapeutics | Feb 2026 | Series A | Co-investor |
| VALANX Biotech | Mar 2026 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Fondation Fournier-Majoie based?
Fondation Fournier-Majoie is headquartered in Brussels, Belgium.
When was Fondation Fournier-Majoie founded?
Fondation Fournier-Majoie was founded in 2007.
How many portfolio companies does Fondation Fournier-Majoie have?
Fondation Fournier-Majoie has 5 portfolio companies in Caplight's dataset.
What are some companies in Fondation Fournier-Majoie's portfolio?
Portfolio companies visible on Caplight include ATB Therapeutics, Precirix, HEPHAISTOS-Pharma, Apmonia Therapeutics, VALANX Biotech.
What was Fondation Fournier-Majoie's most recent investment shown here?
Fondation Fournier-Majoie's most recent investment in this portfolio sample was in VALANX Biotech in 2026.
What sectors does Fondation Fournier-Majoie focus on?
Fondation Fournier-Majoie focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Fondation Fournier-Majoie focus on?
Fondation Fournier-Majoie typically invests at the Early stage.